K Number
K030738
Device Name
SIEMENS MULTIVIEW INFINITY TELEMETRY SYSTEM
Date Cleared
2003-06-06

(88 days)

Product Code
Regulation Number
870.1025
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Use of the INFINITY MultiView WorkStation Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters: - . Heart rate - ECG Arrhythmia Analysis ● - Arterial oxygen saturation ● - Pulse rate - ST segment analysis . The INFINITY MultiView WorkStation (MVWS) Telemetry System with TruST is indicated for use when 12-Lead ECG monitoring with a reduced set of electrodes is desired. Reconstructed leads are intended for real-time assessment of ST segment changes.
Device Description
Siemens' INFINITY MultiView WorkStation Telemetry with TruST enables continuous 12-lead ECG monitoring with a reduced number of electrodes. With TruST only 6 lead wires are required to acquire 12 leads of ECG. TruST relies on conventional lead placement and the INFINITY TruST telemetry transmitters. The TruST matrix uses general reconstruction coefficients to compute 4 precordial leads.
More Information

No
The document describes a system for ECG monitoring and analysis using a "TruST matrix" and "general reconstruction coefficients" to compute leads. There is no mention of AI, ML, or related terms, nor any description of training or test sets typically associated with AI/ML development. The technology described appears to be based on established signal processing techniques for ECG reconstruction.

Yes
This device is a medical device used to measure and monitor physiological parameters (heart rate, ECG, oxygen saturation, pulse rate, and ST segment analysis) in patients, which falls under the definition of a therapeutic device as it aids in the diagnosis and management of patient conditions.

Yes

The device measures and produces visual and audible alarms for physiological parameters like heart rate, ECG arrhythmia, arterial oxygen saturation, and pulse rate, which are used to assess a patient's medical condition. It also performs ST segment analysis and 12-lead ECG monitoring, which are diagnostic indicators for cardiac health.

No

The device description explicitly mentions "INFINITY TruST telemetry transmitters" and "6 lead wires are required to acquire 12 leads of ECG," indicating the presence of hardware components beyond just software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The INFINITY MultiView WorkStation Telemetry System measures and monitors physiological parameters directly from the patient's body (Heart rate, ECG, Arterial oxygen saturation, Pulse rate, ST segment analysis). It does not analyze samples taken from the body.
  • Intended Use: The intended use describes monitoring patient vital signs and ECG, which is a direct measurement from the patient, not an analysis of a sample.

Therefore, this device falls under the category of a patient monitoring system, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The INFINITY MultiView WorkStation (MVWS) Telemetry System is intended to measure and produce visual and audible alarms for one or more physiological parameters

The INFINITY MVWS telemetry System with TruST is intended for 12-Lead ECG monitoring with a reduced set of electrodes. Reconstructed leads are intended for real-time assessment of ST segment changes.

This device is intended for use in an environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.

Use of the INFINITY MultiView WorkStation Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters:

  • . Heart rate
  • ECG Arrhythmia Analysis
  • Arterial oxygen saturation
  • Pulse rate
  • ST segment analysis .

The INFINITY MultiView WorkStation (MVWS) Telemetry System with TruST is indicated for use when 12-Lead ECG monitoring with a reduced set of electrodes is desired. Reconstructed leads are intended for real-time assessment of ST segment changes.

Product codes

MHX, DRG, DRT, BWS, DQA, BZQ, BWX, CAA, FLO, FLS, FLP, DSI, DXJ, MLD, DXN, CCK

Device Description

Siemens' INFINITY MultiView WorkStation Telemetry with TruST enables continuous 12-lead ECG monitoring with a reduced number of electrodes. With TruST only 6 lead wires are required to acquire 12 leads of ECG. TruST relies on conventional lead placement and the INFINITY TruST telemetry transmitters. The TruST matrix uses general reconstruction coefficients to compute 4 precordial leads.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Adult and Pediatric

Intended User / Care Setting

Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, in an environment where patient care is provided.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

  • Assessment of non-clinical performance data for equivalence: Currently there are no FDA standards for this device.
  • Assessment of clinical performance data for equivalence: Section J

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K992595, K024108, K022889, K974698, K980625, K982730, K990563

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).

(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

0

'JUN - 6 2003

510(k) SUMMARY

as required per 807.92(c)

1. Submitters Name, Address:

Siemens Medical Solutions, Inc. Electromedical Systems Group, PCS Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 Official Correspondent: Connie Hertel, Director Quality Assurance & Regulatory Affairs Contact person for this submission: Penelope Greco Date submission was prepared: March 7, 2003

2. Trade Name, Common Name and Classification Name:

A. Trade Name:

SIEMENS INFINITY MultiView WorkStation™ Telemetry System with TruST™

| Common Name | Classification
Number | Class | Regulation Number |
|--------------------------------------------------------------------------|--------------------------|-------|-------------------|
| Monitor, Physiological, Patient (with arrhythmia
detection or alarms) | MHX | III | 21 CFR 870.1025 |
| Radiofrequency physiological signal transmitter
and receiver | 74DRG | II | 21 CFR 870.2910 |
| Cardiac monitor | 74DRT | II | 21 CFR 870.2300 |
| Pulse rate monitor | 74BWS | II | 21 CFR 870.2300 |
| Pulse oximeter | 74DQA | II | 21 CFR 870.2700 |
| Breathing Frequency Monitor | 73BZQ | II | 21 CFR 868.2375 |
| Clinical Electronic Thermometer | 80BWX | II | 21 CFR 880.2910 |
| Indwelling Blood Pressure Monitor | 74CAA | II | 21 CFR 870.1110 |
| Heart Rate Monitor, Neonatal | 74FLO | II | 21 CFR 870.2300 |
| Ventilatory Effort Monitor (Apnea Detector) | 73FLS | II | 21 CFR 868.2375 |
| Monitor Blood Pressure, Neonatal, Invasive | 74FLP | II | 21 CFR 870.1110 |
| Arrhythmia detector & Alarm | 74DSI | III | 21 CFR 870.1025 |
| Medical Cathode-Ray Tube Display | 74DXJ | II | 21 CFR 870.2450 |
| ST Segment Monitor with Alarm | 74MLD | III | 21 CFR 870.1025 |
| Non-indwelling Blood Pressure Monitor | 74DXN | II | 21 CFR 870.1130 |
| End-tidal Carbon-Dioxide Monitor | 73CCK | II | 21 CFR 868.1400 |

B. Common Name, Classification Name, Class and Regulation Number:

Page 1 of 4

COMPANY CONFIDENTIAL

Siemens Medical Solutions, Inc.

Electromedical Systems Group, PCS

16 Electronics Avenue Danvers, MA 01923

Tel: (978) 907-7500 Fax: (978) 750-6879

1

3. Predicate Device Identification:

Philip's (HP) Viridia Component Monitoring System with EASI™ ST Segment- 510(k) K992595

INFINITY MultiView WorkStation Telemetry System Modification - K024108 INFINITY MultiView WorkStation Modifications - K022889 SC 9000 / SC 9015 Enhanced with 12-Lead ST Segment Analysis - 510(k) K974698 MultiView WorkStation Enhanced with Diagnostic Statement (Rest ECG) - 510(k) K980625 SC 7000 / SC 9000XL Infinity Modular Bedside Monitors - 510(k) K982730 SC 8000 w/Advanced Communication Option - 510(k) K990563

Device Description: 4.

Siemens' INFINITY MultiView WorkStation Telemetry with TruST enables continuous 12-lead ECG monitoring with a reduced number of electrodes. With TruST only 6 lead wires are required to acquire 12 leads of ECG. TruST relies on conventional lead placement and the INFINITY TruST telemetry transmitters. The TruST matrix uses general reconstruction coefficients to compute 4 precordial leads.

5. Intended Use:

The INFINITY MultiView WorkStation (MVWS) Telemetry System is intended to measure and produce visual and audible alarms for one or more physiological parameters

The INFINITY MVWS telemetry System with TruST is intended for 12-Lead ECG monitoring with a reduced set of electrodes. Reconstructed leads are intended for real-time assessment of ST segment changes.

This device is intended for use in an environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.

Page 2 of 4

COMPANY CONFIDENTIAL

Siemens Medical Solutions, Inc.

Electromedical Systems Group, PCS

16 Electronics Avenue Danvers, MA 01923

Tel: (978) 907-7500 Fax: (978) 750-6879 050-38

: Of

2

030738 50F )

510(k) Notification
SIEMENS INFINITY MultiView WorkStation™ Telemetry with TruST™

Table of Device Similarities and differences to predicate device
ManufacturerSubstantial Equivalent DeviceSubstantial Equivalent DeviceApplicantExplanation of
Differences
(k) NumberHP Viridia Component
Monitoring System with EASITM
ST Segment Measurement
Philips (HP)SC 9000 / SC 9015 Bedside
Monitoring System Enhanced with
12-Lead ST Segment Analysis
Siemens Medical SolutionsSiemens Medical Systems Infinity
MultiView WorkStation Telemetry
System with TruST
Siemens Medical Solutions
K992595K974698To be assigned
Intended UseAssessment of real time ST
segment analysis in adult
patients.To determine the ST Segment of the
ECG signal and to compute the
deviation of this ST Segment from
the iso-electric point (baseline).The INFINITY MultiView
WorkStation (MVWS) Telemetry
System is intended to measure and
produce visual and audible alarms
for one or more physiological
parametersSimilar to Philips' Easi
in that the MVWS with
TruST monitors 12-lead
ECG with a reduced set
of electrodes.
Intended PopulationAdultAdult/PediatricThe INFINITY MVWS telemetry
System with TruST is intended
for 12-Lead ECG monitoring with a
reduced set of electrodes.
Reconstructed leads are intended for
real-time assessment of ST segment
changes.
Intended
EnvironmentIn the medical clinic or hospital
environment for use by
physicians, nurses and ECG
technicians.Adult/PediatricSame
Diagnostic
ST AnalysisNoYesNo
Up to 12 Derived ComplexesUp to 12 Measured ST ComplexesUp to 8 Measured ST Complexes
Up to 4 Derived ST ComplexesdV1, dV3, dV4, dV6
5126

Page 3 of 4

COMPANY CONFIDENTIA

16 Electronics Avenue
Danvers, MA 01923

Tel: (978) 907-7500
Fax: (978) 750-6879

Siemens Medical Solutions,
Electromedical Systems Group, PCS

3

    1. Assessment of non-clinical performance data for equivalence: Currently there are no FDA standards for this device.
    1. Assessment of clinical performance data for equivalence: Section J
    1. Biocompatability: Not applicable
    1. Sterilization: Not applicable
    1. Standards and Guidances: Section P

Page 4 of 4

COMPANY CONFIDENTIAL

Siemens Medical Solutions, Inc. Electromedical Systems Group, PCS

16 Electronics Avenue Danvers, MA 01923

Tel: (978) 907-7500 Fax: (978) 750-6879

K 0 30 7 38 by afy

4

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, overlapping each other.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN - 6 2003

Ms. Penelope H. Greco Regulatory Submissions Manager Siemens Medical Solutions, Inc. Electromedical Systems Group, PCS 16 Electronics Avenue Danvers, MA 01923

Re: K030738

Trade Name: MultiView WorkStation Telemetry System with TruSTTM Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia detector and alarm Regulatory Class: Class III (three) Product Code: MHX Dated: March 7, 2003 Received: March 10, 2003

Dear Ms. Greco:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

5

Page 2 - Ms. Penelope H. Greco

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Bram D. Zuckerman, M.D.

Director Division of Cardiovascular Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

6

510(k) Number (if known): K030738

Siemens Infinity MultiView WorkStation Telemetry System Device Name: Enhanced with TruST™

Indications for Use:

Use of the INFINITY MultiView WorkStation Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters:

  • . Heart rate
  • ECG Arrhythmia Analysis ●
  • Arterial oxygen saturation ●
  • Pulse rate
  • ST segment analysis .

The INFINITY MultiView WorkStation (MVWS) Telemetry System with TruST is indicated for use when 12-Lead ECG monitoring with a reduced set of electrodes is desired. Reconstructed leads are intended for real-time assessment of ST segment changes.

MRI Compatibility Statement:

The Infinity MultiView WorkStation Telemetry System is not compatible for use in a MRI magnetic field.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use
(Per 21 CFR 801.109)

OR

Over-The-Counter Use

(Optional Format 1-2-96)

N. Carter